EBITDA stood at RON0.69 million, compared with RON1.3 million in the first half of 2025. IT Genetics also made consolidated net loss of RON0.45 million, after turning a net profit of RON0.53 million in the year-ago period.
The profitability trend was influenced both by lower activity levels in certain traditional verticals – in an economic context characterized by investment caution and prolonged business cycles, and by continued investments in team expansion, the development of international operations, proprietary products, and new lines of business, company representatives said in a press release.
The company went public on the Bucharest Stock Exchange this spring and currently has a market capitalization of RON35 million on the AeRO market, following a 6.5% decline in its stock price over the past month.
(English version by Loredana Fratila-Cristescu)